Sabra Healthcare REIT (NASDAQ:SBRA) Hits New 1-Year High on Analyst Upgrade

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)’s share price reached a new 52-week high during mid-day trading on Wednesday after UBS Group raised their price target on the stock from $20.00 to $21.00. UBS Group currently has a neutral rating on the stock. Sabra Healthcare REIT traded as high as $20.70 and last traded at $20.59, with a volume of 3777379 shares trading hands. The stock had previously closed at $20.17.

Other analysts have also recently issued reports about the stock. Citizens Jmp upped their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday. Cantor Fitzgerald boosted their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Tuesday. Wells Fargo & Company raised their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Truist Financial lifted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a report on Tuesday, January 20th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Thursday, January 22nd. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, Sabra Healthcare REIT has an average rating of “Moderate Buy” and a consensus price target of $21.70.

Institutional Trading of Sabra Healthcare REIT

A number of hedge funds and other institutional investors have recently bought and sold shares of SBRA. Rothschild Investment LLC boosted its stake in shares of Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 889 shares during the period. Smartleaf Asset Management LLC lifted its holdings in Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 714 shares in the last quarter. Founders Capital Management purchased a new stake in Sabra Healthcare REIT in the 3rd quarter valued at about $28,000. Strengthening Families & Communities LLC bought a new position in Sabra Healthcare REIT in the 4th quarter worth about $29,000. Finally, Danske Bank A S bought a new position in Sabra Healthcare REIT in the 3rd quarter worth about $30,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Down 0.5%

The stock’s 50-day moving average price is $19.13 and its 200 day moving average price is $18.82. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. The firm has a market capitalization of $5.02 billion, a PE ratio of 31.10, a price-to-earnings-growth ratio of 1.61 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). The firm had revenue of $201.35 million during the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The firm’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same period last year, the company earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 187.50%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.